Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

J Appl Physiol 57: 1783-1789, 1984;
8750-7587/84 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roum, J. H.
Right arrow Articles by Murlas, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roum, J. H.
Right arrow Articles by Murlas, C.

Journal of Applied Physiology, Vol 57, Issue 6 1783-1789, Copyright © 1984 by American Physiological Society

ARTICLES

Ozone-induced changes in muscarinic bronchial reactivity by different testing methods

J. H. Roum and C. Murlas

We examined the effect of ozone (O3) on muscarinic bronchial reactivity in the guinea pig and compared reactivity determined by two different routes of agonist delivery. Reactivity before and from 4 h to 2 days after O3 exposure (3.0 ppm, 2 h) was determined by measuring specific airway resistance upon administration of intravenous acetylcholine and/or aerosolized methacholine challenge in 34 unanesthetized, spontaneously breathing animals. Before exposure, we observed more gradual and reproducible results to intravenous agonist. After exposure, hyperreactivity to parenteral agonist occurred consistently, but not to inhaled agonist. Hyperreactivity demonstrable by either route was similar in magnitude and time course within 14 h of exposure. Two days later, hyperreactivity to inhaled agonist had remitted; that to intravenous drug persisted. Our results indicate that variability in the occurrence and time course of O3-induced hyperreactivity to inhaled agonist may be a consequence of the technique employed. The consistent occurrence of hyperreactivity after O3 to parenteral agonist suggests mechanisms other than airway mucosal hyperpermeability are responsible for this hyperreactivity.


This article has been cited by other articles:


Home page
 J. Appl. Physiol.Home page
B. Sommer, M. H. Vargas, J. Chavez, V. Carbajal, P. Segura, and L. M. Montano
Differences between inhaled and intravenous bronchial challenge to detect O3-induced hyperresponsiveness
J Appl Physiol, December 1, 2001; 91(6): 2595 - 2601.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
H. INOUE, H. AIZAWA, H. NAKANO, K. MATSUMOTO, K. KUWANO, J. A. NADEL, and N. HARA
Nitric Oxide Synthase Inhibitors Attenuate Ozone-induced Airway Inflammation in Guinea Pigs . Possible Role of Interleukin-8
Am. J. Respir. Crit. Care Med., January 1, 2000; 161(1): 249 - 256.
[Abstract] [Full Text]

Home page
 J. Appl. Physiol.Home page
N. Noviski, J. P. Brewer, W. A. Skornik, S. J. Galli, J. M. Drazen, and T. R. Martin
Mast cell activation is not required for induction of airway hyperresponsiveness by ozone in mice
J Appl Physiol, January 1, 1999; 86(1): 202 - 210.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online